Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.305 USD | +0.91% | +2.53% | -17.45% |
04-26 | Cytokinetics Appoints Sung Lee as CFO | MT |
04-18 | Vir Biotechnology, Inc. Announces Stepping Down of Sung Lee as Chief Financial Officer, Effective May 3, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.45% | 1.12B | |
+2.16% | 42.75B | |
+47.58% | 41.61B | |
+12.37% | 41.34B | |
-12.36% | 26.59B | |
+8.68% | 25.49B | |
-23.23% | 18.12B | |
+30.25% | 12.24B | |
-1.39% | 11.76B | |
+8.61% | 11B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology Doses First Patients in Phase 2 SOLSTICE Trial Evaluating Chronic Hepatitis D Virus Infection